Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Nature Medicine

• Publication date

  2015-06-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nm.3897PMID 26121193PMCID PMC5716342
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

  2015cited by this paper
• Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

  2015cited by this paper
• Integrative analysis of 111 reference human epigenomes

  2015cited by this paper
• A new initiative on precision medicine.

  2015cited by this paper
• Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis

  2015cited by this paper
• Comparative Genomic Profiling of Synovium Versus Skin Lesions in Psoriatic Arthritis

  2015cited by this paper
• Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

  2015cited by this paper
• Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: Safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial.

  2015cited by this paper
• Secukinumab in plaque psoriasis--results of two phase 3 trials.

  2014cited by this paper
• Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression

  2014cited by this paper
• Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment.

  2014cited by this paper
• Not all monoclonals are created equal - lessons from failed drug trials in Crohn's disease.

  2014cited by this paper
• Early-onset Crohn’s disease and autoimmunity associated with a variant in CTLA-4

  2014cited by this paper
• Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies

  2014cited by this paper
• Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis.

  2014cited by this paper
• Genetic and Epigenetic Fine-Mapping of Causal Autoimmune Disease Variants

  2014cited by this paper
• Statin-related cognitive impairment in the real world: you'll live longer, but you might not like it.

  2014cited by this paper
• A 52-week placebo-controlled trial of evolocumab in hyperlipidemia.

  2014cited by this paper
• Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

  2014cited by this paper
• PTPN22: the archetypal non-HLA autoimmunity gene

  2014cited by this paper
• Guidelines for investigating causality of sequence variants in human disease

  2014cited by this paper
• Anatomical localization of commensal bacteria in immune cell homeostasis and disease

  2014cited by this paper
• Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)

  2014cited by this paper
• Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

  2013cited by this paper
• Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis

  2013cited by this paper
• Ustekinumab in the treatment of psoriatic arthritis: latest findings and clinical potential

  2013cited by this paper
• Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis

  2013cited by this paper
• Population genetic tools for dissecting innate immunity in humans

  2013cited by this paper
• Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: a 24-week, randomised, double-blind, placebo-controlled, phase II proof-of-concept trial

  2013cited by this paper
• Genetics of rheumatoid arthritis contributes to biology and drug discovery

  2013cited by this paper
• Genetics of rheumatoid arthritis contributes to biology and drug discovery

  2013cited by this paper
• Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.

  2013cited by this paper
• Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial.

  2013cited by this paper
• The human skin-associated autoantigen α-NAC activates monocytes and dendritic cells via TLR-2 and primes an IL-12-dependent Th1 response.

  2013cited by this paper
• How Cytokine Networks Fuel Inflammation: Toward a cytokine-based disease taxonomy

  2013cited by this paper
• Genetic insights into common pathways and complex relationships among immune-mediated diseases

  2013cited by this paper
• Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β

  2012cited by this paper
• Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

  2012cited by this paper
• Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis

  2012cited by this paper
• Materials for : Host-microbe interactions shape genetic risk for inflammatory bowel disease

  2012cited by this paper
• TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

  2012cited by this paper
• Human gut microbiome viewed across age and geography

  2012cited by this paper
• Characterization of TLR4-mediated auto-antibody production in a mouse model of histidyl-tRNA synthetase-induced myositis

  2012cited by this paper
• High density genetic mapping identifies new susceptibility loci for rheumatoid arthritis

  2012cited by this paper
• [Effect of a monoclonal antibody to PCSK9 on LDL cholesterol].

  2012cited by this paper
• Seven newly identified loci for autoimmune thyroid disease

  2012cited by this paper
• Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

  2012cited by this paper
• Twin studies in autoimmune disease: genetics, gender and environment.

  2012cited by this paper
• Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

  2012cited by this paper
• Effect of a monoclonal antibody to PCSK9 on LDL cholesterol.

  2012cited by this paper
• Innate Lymphoid Cells Promote Anatomical Containment of Lymphoid-Resident Commensal Bacteria

  2012cited by this paper
• Interactions Between the Microbiota and the Immune System

  2012cited by this paper
• Abatacept for Crohn's disease and ulcerative colitis.

  2012cited by this paper
• Rituximab Treatment for Spondyloarthritis. A Nationwide Series: Data from the AIR Registry of the French Society of Rheumatology

  2012cited by this paper
• Hiding under the skin: A welcome surprise in psoriasis

  2012cited by this paper
• Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses

  2011cited by this paper
• Integrating Autoimmune Risk Loci with Gene-Expression Data Identifies Specific Pathogenic Immune Cell Subsets.

  2011cited by this paper
• The value of early intervention in RA—a window of opportunity

  2011cited by this paper
• Functional Studies on the IBD Susceptibility Gene IL23R Implicate Reduced Receptor Function in the Protective Genetic Variant R381Q

  2011cited by this paper
• Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease

  2011cited by this paper
• The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans

  2011cited by this paper
• Integrating autoimmune risk loci with gene-expression data identifies specific pathogenic immune cell subsets.

  2011cited by this paper
• Human nutrition, the gut microbiome and the immune system

  2011cited by this paper
• Genomics and the multifactorial nature of human autoimmune disease.

  2011cited by this paper
• The autoimmune disease–associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness

  2011cited by this paper
• Reengineering Translational Science: The Time Is Right

  2011cited by this paper
• Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis.

  2010cited by this paper
• Trait-Associated SNPs Are More Likely to Be eQTLs: Annotation to Enhance Discovery from GWAS

  2010cited by this paper
• Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis

  2010cited by this paper
• No evidence of differential effects of SFA, MUFA or PUFA on post-ingestive satiety and energy intake: a randomised trial of fatty acid saturation

  2010cited by this paper
• Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

  2010cited by this paper
• Adaptation – not by sweeps alone

  2010cited by this paper
• Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.

  2010cited by this paper
• The Jewish encyclopedia: a guide to its contents, an aid to its use

  2010cited by this paper
• Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells

  2010cited by this paper
• Th17 and regulatory T cells in mediating and restraining inflammation.

  2010cited by this paper
• A protective function for interleukin 17A in T cell–mediated intestinal inflammation

  2009cited by this paper
• Mechanisms of Disease: Psoriasis.

  2009cited by this paper
• PTPN 22 Deficiency Cooperates with the CD 45 E 613 R Allele to Break Tolerance on a Non-Autoimmune Background 1

  2009cited by this paper
• Rheumatoid arthritis

  2009cited by this paper
• Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling1

  2009cited by this paper
• PTPN22 Deficiency Cooperates with the CD45 E613R Allele to Break Tolerance on a Non-Autoimmune Background1

  2009cited by this paper
• Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.

  2009cited by this paper
• Plasticity of CD4+ T cell lineage differentiation.

  2009cited by this paper
• A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis

  2008cited by this paper
• Innate immunity and intestinal microbiota in the development of Type 1 diabetes

  2008cited by this paper
• B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

  2008cited by this paper
• TGF-beta: a master of all T cell trades.

  2008cited by this paper
• B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

  2008cited by this paper
• Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways

  2008cited by this paper
• The genetics and immunopathogenesis of inflammatory bowel disease

  2008cited by this paper
• A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.

  2007cited by this paper
• T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.

  2007cited by this paper
• A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.

  2007cited by this paper
• Scientific and regulatory considerations on the immunogenicity of biologics.

  2006cited by this paper
• A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

  2006cited by this paper
• Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial

  2006cited by this paper
• Infliximab for induction and maintenance therapy for ulcerative colitis.

  2005cited by this paper
• TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques1

  2005cited by this paper
• Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant

  2005cited by this paper

• Plant‐Based Food Preferences Rich in Polyphenols and Their Causal Effects on Inflammatory Bowel Disease

  2026cites this paper
• Intralesional Corticosteroid Therapy for Isolated Immunoglobulin G4-Related Esophageal Involvement: A Novel Approach to a Rare Condition.

  2026cites this paper
• Engineering red blood cells for antigen-specific immune tolerance and personalized therapy of autoimmune diseases.

  2026cites this paper
• The shared genetic architecture underlying the autoimmune and cardiovascular disease: a multivariate genome-wide analysis

  2026cites this paper
• Multi-omics-driven biomarker discovery in autoimmune diseases: a comprehensive review

  2025cites this paper
• Emerging roles of mechanically activated ion channels in autoimmune disease.

  2025cites this paper
• Prevalence and Risk Factors of Autoimmune Thyroid and Coeliac Disease in Type 1 Diabetes Children and Adolescents; A Retrospective Cohort Analysis

  2025cites this paper
• Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosis

  2025cites this paper
• The Role of Fc-like Receptor 3 in the Pathophysiology of Rheumatoid Arthritis

  2025cites this paper
• Cold Atmospheric Plasma in the Treatment of Autoimmune Diseases: Mechanisms, Applications, and Prospects

  2025cites this paper
• Crossroads between autoimmunity and cancer: Underlying mechanisms and clinical implications.

  2025cites this paper
• Establishing an RNA sensor with high sensitivity and dynamic range utilizing a signal amplifier platform

  2025cites this paper
• Occupational dust and chemical exposures and the development of autoimmune rheumatic diseases

  2025cites this paper
• Peptide/Antibody–Drug Conjugates for Therapeutic Applications in Inflammatory Disease

  2025cites this paper
• Identification of Potential Nontoxic Human BTK Inhibitors through an Integrated Deep Learning and Structure-Based Drug Repositioning Strategy

  2025cites this paper
• The induction of type I interferonopathy in Trex1-P212fs mice is mediated by activation of the cGAS-STING pathway.

  2025cites this paper
• PULSAR: a Foundation Model for Multi-scale and Multi-cellular Biology

  2025cites this paper
• Autoencoder-Based Representation Learning for Similar Patients Retrieval From Electronic Health Records: Comparative Study

  2025cites this paper
• Defining minimal criteria for peer-reviewed reporting of mesenchymal stromal cell clinical trials for autoimmune diseases.

  2025cites this paper
• Metabolomic and machine learning enhances patient diagnosis and stratification in systemic autoimmune diseases

  2025cites this paper
• [Advances in pharmacotherapy for immunoinflammatory rheumatic diseases in the 21st century].

  2025cites this paper
• Artificial intelligence for autoimmune diseases

  2025cites this paper
• Nanotechnology and cell death: Revolutionizing disease treatment with nanoparticle strategies

  2025cites this paper
• The role of CRISPR-Cas9 and CRISPR interference technologies in the treatment of autoimmune diseases.

  2025cites this paper
• Functional dissection of noncoding variants associated with rheumatoid arthritis.

  2025cites this paper
• Microfluidic single‐cell technologies for immunotherapeutic target discovery: From design concepts to preclinical applications

  2025cites this paper
• The Integrated Cellular and Molecular Landscape of Autoimmunity

  2025cites this paper
• Investigating Overlapping Genetic Factors and Novel Causal Genes in Autoimmune Diseases: A Transcriptome-Wide Association and Multiomics Study

  2025cites this paper
• The immunoregulatory effects of total glucosides of paeony in autoimmune diseases.

  2024cites this paper
• Large-scale cross-trait genetic analysis highlights shared genetic backgrounds of autoimmune diseases

  2024cites this paper
• An overview on Sjögren’s syndrome and systemic lupus erythematosus’ genetics

  2024cites this paper
• Noble Metal Nanoparticle‐Based Aptasensors: A Powerful Tool for Exosomal Detection

  2024cites this paper
• Autoimmune disease: a view of epigenetics and therapeutic targeting

  2024cites this paper
• Auto-immuno-deficiency syndromes.

  2024cites this paper
• Targeting the TNF and TNFR superfamilies in autoimmune disease and cancer

  2024cites this paper
• Multiomics approaches disclose very-early molecular and cellular switches during insect-venom allergen-specific immunotherapy: an observational study

  2024cites this paper
• Anti-IL-17 bioactivity-guided fractionation of a pine bio-oil: Chemical characterization and impact on HaCaT human keratinocytes gene expression

  2024cites this paper
• Microenvironment responsive hydrogel exerting inhibition of Cascade immune activation and elimination of synovial fibroblasts for rheumatoid arthritis therapy.

  2024cites this paper
• Exposure to Environmental Toxins & Autoimmune Conditions.

  2024cites this paper
• Effects of genetically predicted posttraumatic stress disorder on autoimmune phenotypes

  2024cites this paper
• Recent Advances of Engineered Cell Membrane-Based Nanotherapeutics to Combat Inflammatory Diseases.

  2024cites this paper
• Regulation of immunomodulatory networks by Nrf2-activation in immune cells: Redox control and therapeutic potential in inflammatory diseases

  2024cites this paper
• Identification of the shared genetic architecture underlying seven autoimmune diseases with GWAS summary statistics

  2024cites this paper
• Dissecting the Immune System through Gene Regulation.

  2024cites this paper
• Machine learning and artificial intelligence within pediatric autoimmune diseases: applications, challenges, future perspective

  2024cites this paper
• Harnessing autoimmunity with dominant self-peptide: Modulating the sustainability of tissue-preferential antigen-specific Tregs by governing the binding stability via peptide flanking residues.

  2023cites this paper
• Philadelphia chromosome-negative myeloproliferative chronic neoplasms: is clonal hematopoiesis the main determinant of autoimmune and cardio-vascular manifestations?

  2023cites this paper
• Large-scale integrative analysis of juvenile idiopathic arthritis for new insight into its pathogenesis

  2023cites this paper
• Rationalizing a prospective coupling effect of cannabinoids with the current pharmacotherapy for melanoma treatment.

  2023cites this paper
• Post-transcriptional checkpoints in autoimmunity

  2023cites this paper
• Current state and completeness of reporting clinical prediction models using machine learning in systemic lupus erythematosus: A systematic review.

  2023cites this paper
• Cord serum metabolic signatures of future progression to immune-mediated diseases

  2023cites this paper
• Biomarker-driven development of new therapies for autoimmune diseases: current status and future promises

  2023cites this paper
• Cationic nanoparticles-based approaches for immune tolerance induction in vivo.

  2023cites this paper
• Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis

  2023cites this paper
• Innate and adaptive immune abnormalities underlying autoimmune diseases: the genetic connections

  2023cites this paper
• Characteristics of adult-onset auto-immune type1 diabetes.

  2023cites this paper
• Macrophage Targeting by Nanocarriers for Therapy of Autoimmune Diseases

  2022cites this paper
• Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases

  2022cites this paper
• Past, Present and Future Perspective of Application of Nanobiotechnology in Pharmacology and Innovative Therapeutics

  2022cites this paper
• Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease

  2022cites this paper
• Clinical implications of tristetraprolin (TTP) modulation in the treatment of inflammatory diseases.

  2022cites this paper
• Cell-type-specific transcriptome architecture underlying the establishment and exacerbation of systemic lupus erythematosus

  2022cites this paper
• The effect of chemotherapy in patients with stage I mucinous ovarian cancer undergoing fertility-sparing surgery

  2022cites this paper
• Proteomics and Its Role in Diagnosis of Auto Immune Diseases

  2022cites this paper
• Neuroradiological manifestations of neuroinflammatory diseases; A concept for rare cases and neuro-COVID-19

  2022cites this paper
• Genetic Polymorphism of PTPN22 in Autoimmune Diseases: A Comprehensive Review

  2022cites this paper
• A Summary on the Genetics of Systemic Lupus Erythematosus, Rheumatoid Arthritis, Systemic Sclerosis, and Sjögren’s Syndrome

  2022cites this paper
• Construction and Application of Polygenic Risk Scores in Autoimmune Diseases

  2022cites this paper
• Relationship Between a Vitamin D Genetic Risk Score and Autoantibodies Among First-Degree Relatives of Probands With Rheumatoid Arthritis and Systemic Lupus Erythematosus

  2022cites this paper
• Single-cell profiling to transform immunotherapy usage and target discovery in immune-mediated inflammatory diseases

  2022cites this paper
• Periodontitis and risk of immune-mediated systemic conditions: A systematic review and meta-analysis.

  2022cites this paper
• PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses

  2022cites this paper
• POSITIONAL CLONING OF POLYMORPHIC LOCI THAT CONTROL AUTOREACTIVE T CELLS

  2021cites this paper
• Network pharmacology: curing causal mechanisms instead of treating symptoms.

  2021cites this paper
• Application of Data Science Approaches to Investigate Autoimmune Thyroid Disease in Precision Medicine

  2021cites this paper
• Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature

  2021cites this paper
• Immune Sexual Dimorphism: Connecting the Dots.

  2021cites this paper
• IL27 T4730C Polymorphism and Serology in Multiple Sclerosis: A Pilot Study

  2021cites this paper
• Exposure to Environmental Toxins and Autoimmune Conditions.

  2021cites this paper
• Endocrine Disorders in Autoimmune Rheumatological Diseases: A Focus on Thyroid Autoimmune Diseases and on the Effects of Chronic Glucocorticoid Treatment

  2021cites this paper
• Multi-omics approach to precision medicine for immune-mediated diseases

  2021cites this paper
• Treating Autoimmune Inflammatory Diseases with an siERN1-Nanoprodrug That Mediates Macrophage Polarization and Blocks Toll-like Receptor Signaling.

  2021cites this paper
• Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?

  2021cites this paper
• Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis

  2021cites this paper
• Global climate change, diet, and the complex relationship between human host and microbiome: Towards an integrated picture

  2021cites this paper
• Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases.

  2021cites this paper
• Thyrotrophin and thyroxine support immune homeostasis in humans

  2021cites this paper
• Nanomedicines for the treatment of rheumatoid arthritis: State of art and potential therapeutic strategies

  2021cites this paper
• New confinement index and new perspective for comparing countries - COVID-19

  2021cites this paper
• Restoring immunological tolerance in established experimental arthritis by combinatorial citrullinated peptides and immunomodulatory signals

  2021cites this paper
• IgG Fc N-glycosylation translates MHCII haplotype into autoimmune skin disease.

  2020cites this paper
• Urine and serum S100A8/A9 and S100A12 associate with active lupus nephritis and may predict response to rituximab treatment

  2020cites this paper
• Detecting pathogenic variants in autoimmune diseases using high‐throughput sequencing

  2020cites this paper
• Higher prevalence of thyroid dysfunction in patients with erythrodermic psoriasis

  2020cites this paper
• Germline Genetic Determination of Cancer Outcome

  2020cites this paper
• Genetic Influences on Disease Subtypes.

  2020cites this paper
• Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study

  2020cites this paper
• Myocarditis in Systemic Immune-Mediated Diseases

  2020cites this paper
• Naming HLA diversity: A review of HLA nomenclature.

  2020cites this paper